Deer Park, IL – According to filings with the U.S. Securities and Exchange Commission, Eton Pharmaceuticals is raising $7,500,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Wilson Troutman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Eton Pharmaceuticals

Eton Pharmaceuticals, Inc. is a Deer Park, Illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the U.S. Food and Drug Administration’s 505(b)(2) regulatory pathway. Our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.

To learn more about Eton Pharmaceuticals, visit http://etonpharma.com/

Contact:
Wilson Troutman, Chief Financial Officer
847-616-5734
https://www.linkedin.com/in/wilson-troutman-6793586/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved